4//SEC Filing
LABORATORY CORP OF AMERICA HOLDINGS 4
Accession 0001127602-15-024050
$LHCIK 0000920148operating
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 2:15 PM ET
Size
8.4 KB
Accession
0001127602-15-024050
Insider Transaction Report
Form 4
HERRING JOSEPH L
CEO of Covance Drug Division
Transactions
- Exercise/Conversion
Restricted Stock Unit
2015-07-31−19,990→ 0 totalFrom: 2015-07-31→ Common Stock (19,990 underlying) - Exercise/Conversion
Common Stock
2015-07-31+19,990→ 19,990 total - Tax Payment
Common Stock
2015-07-31$127.29/sh−9,586$1,220,202→ 10,404 total
Footnotes (3)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]On February 23, 2015, the reporting person was granted 19,990 Restricted Stock Units, which vested in full on July 31, 2015.
Documents
Issuer
LABORATORY CORP OF AMERICA HOLDINGS
CIK 0000920148
Entity typeoperating
Related Parties
1- filerCIK 0000920148
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 2:15 PM ET
- Size
- 8.4 KB